In addition to potentiating growth and migration, CXCL12 has been shown to protect pancreatic cancer cells from the cytotoxic effects of the PDAC standard-of-care drug gemcitabine [70,74]. Here, CXCL12 is linked to familial pancreatic carcinoma.